Nicola Maria Schmitt

Suggest Changes
Learn More
OBJECTIVE This trial compared the efficacy/safety of two IV doses of AZD9773, a polyclonal antibody to tumor necrosis factor-α, in adult patients with severe sepsis/septic shock. DESIGN(More)
  • 1